Abstract. ApoE plays a key role in various biological events.
Introduction
Gastric cancer is one of the most life-threatening cancers worldwide, however, clinical outcome has gradually improved over the last decades. This is mainly due to the prevalence of endoscopic technology, which allows detecting gastric cancer at early stages (1) . When tumors are localized within the mucosal layer, endoscopic mucosal resection (EMR) can be successfully performed. However, because of an expansion of the criteria for endoscopic procedure, the tumors have been endoscopically resected as endoscopic submucosal dissection (ESD), even though invasion was through the submucosal layer (2) . In order to determine whether gastric cancers detected at early stages are eligible for endoscopic local treatments, it is required to evaluate the presence of lymph node metastasis and the depth of tumor invasion with accuracy.
Studies on differential gene expression between gastric cancer and metastatic lymph node using microarray or serial analysis of gene expression (SAGE) technique have been published (3) (4) (5) . Among them, Oue et al demonstrated that Apolipoprotein E (ApoE) is highly expressed in the metastastic lymph node (6) .
ApoE is a secretory glycoprotein that mediates lipid metabolism by binding to the low-density lipoprotein (LDL) receptor (7) . Its ligand-receptor binding also activates various signal transductions (8) (9) (10) . Therefore, it has been suggested that ApoE not only regulates lipid metabolism but also plays a key role in biological events such as nerve regeneration, antioxidant effects, immune response and cell proliferation (11) (12) (13) . Moreover, concerning cancer field, ApoE has been correlated with cancer development in epithelial malignancies such as ovary or prostate (14) (15) (16) .
However, to the authors' knowledge, there is no available information concerning ApoE expression in gastric cancer. Based on previous data from other cancer studies, we hypothesized that ApoE would show biological activity for promotion of lymph node metastasis in gastric cancer. Since it is important in clinical applications to acquire the samples as easily as possible, we focused on ApoE expression in primary site, not the metastatic lymph node. The aim of this study is to clarify clinical significance of ApoE expression in gastric cancer.
Materials and methods
Clinical bulk samples. Clinical bulk samples were collected from a total of 124 patients suffering from primary gastric cancer. All patients underwent surgery without pre-operative treatments such as chemotherapy at our institute from 1989 to 2000. Immediately after the operation, bulk samples were carefully removed from tumor tissue (T) and the corresponding normal tissue (N), and frozen with RNAlater (Ambion, Austin, TX, USA) at -80˚C until RNA extraction. The cDNA was then reverse-transcribed from 8.0 μg of total RNA extracted using Isogen (Nippon Gene, Tokyo, Japan), followed by real-time quantitative RT-PCR assay (17) . All of the patients were regularly observed every month, for an average follow-up period of 2.4 years. Histopathological evaluations were done with reference to the Japanese Classification of Gastric Carcinoma, 2nd English edition (18, 19) , and the relationship between ApoE mRNA expression and clinicopathologic factors was statistically analyzed. This study was conducted under the supervision of the ethics board of Kyushu University.
Laser microdissection (LMD) samples. To address ApoE mRNA expression, a laser microdissection (LMD) system (Leica LMD System, Leica Microsystems, Wetzlar, Germany) was used as previously described (20) . Briefly, four frozen samples were selected from 124 samples, and were sectioned with a cryostat (Leica Microsystems) at 8 μm in thickness. The sliced samples were quickly fixed with a mixture of 100% ethanol and acetic anhydride (18:1). After staining with hematoxylin-eosin, the gastric cancer was differentially dissected from stromal cells using the LMD system. Similarly, the adjacent normal epithelium was also dissected. Total RNA was then extracted using an RNeasy micro kit (Qiagen, Hiden, Germany), followed by real-time quantitative RT-PCR assay.
Real-time quantitative reverse transcription (RT)-PCR assay.
The real-time quantitative monitoring of PCR reactions was performed in the LightCycler System (Roche Applied Science, Indianapolis, IN, USA) using the LightCycler FastStart DNA Master SYBR Green I kit (Roche Diagnostics, Mannheim, Germany). ApoE gene specific primers were designed as follows: 5'-GGTCGCTTTTGGGATTACCT-3' (sense) and 5'-CCTTCAACTCCTTCATGGTCTC-3' (anti-sense). To verify quality and integrity of synthesized cDNA, the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as an internal control: 5'-TTGGTATCGTGGAAG GACTCA-3' (sense) and 5'-TGTCATCATATTTGGCAG GTT-3' (anti-sense). Cycling conditions consisted of 36 cycles of denaturation at 95˚C for 10 sec, annealing at 66˚C (60˚C for GAPDH) for 10 sec and elongation at 72˚C for 8 sec. The amplicons were subjected to a temperature gradient to produce a melting curve of the products. A single peak verified the purity of each product.
The standard curve was plotted by two-fold serial dilutions of cDNAs made from Human Universal Reference total RNA (Clontech, Palo Alto, CA, USA). The amount of ApoE and GAPDH mRNA expression was calculated in proportion to that of the cDNA of Human Universal Reference total RNA. Normalization was achieved by dividing each calculated value of ApoE expression by the level of GAPDH expression.
Immunohistochemistry. ApoE protein expression was visualized with immunohistochemical staining of surgical specimens from gastric cancer patients. Sections of formalin-fixed, paraffin-embedded tissues were subjected 
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to antigen-antibody reactions with mouse monoclonal antibody against ApoE (BD Biosciences Pharmingen, San Diego, CA, USA). ApoE specific antibody was used at a dilution of 1:2000. The antigen-antibody reactions were visualized using the streptavidin-biotin-peroxidase method (LSAB Kit, Dako, Kyoto, Japan). All sections were counterstained with hematoxylin.
Statistical analysis. The study samples were classified into two groups (higher expression group: n=62, lower expression group: n=62) by the median ApoE mRNA expression in tumor tissue of bulk samples.
All statistical analysis was carried out using JMP 5 for Windows software (SAS Institute Inc. Cary, NC, USA) The differences between these two groups, based on clinicopathologic factors, were statistically analyzed using Student's t-test and Chi-square test. The survival curve was plotted according to the Kaplan-Meier method, and log-rank test was done to compare the survival rate. Multivariate analysis for survival was performed using the Cox proportional hazards regression model, while multivariate analysis for lymph node metastasis and muscular invasion was performed using the logistic regression model. If the probability value was <0.05, the difference was considered statistically significant.
Results
ApoE mRNA expression in bulk samples. We examined ApoE mRNA expression in gastric cancer. Fig. 1A shows gel images of ApoE mRNA expression, and Fig. 1B shows the result of real-time RT-PCR assay for 124 bulk samples. Significant difference (p<0.0001; Student's t-test) in ApoE mRNA expression between tumor and normal tissue was observed. In 83 of 124 patients (66.9%), the ApoE mRNA expression level was frequently higher in tumor tissue than in the corresponding normal tissue (the mean expression level in tumor tissue was 0.54, and 0.28 in the corresponding normal tissue).
ApoE expression in LMD samples. Fig. 2A shows ApoE mRNA expression in the specimens which were dissected using the LMD system. ApoE mRNA expression in gastric cancer was higher than expression in the adjacent normal epithelium.
Immunohistochemistry. Immunohistochemical staining revealed that ApoE protein was predominantly expressed in cancer tissue (Fig. 2B) . None of the stromal cells stained positively for ApoE expression. 
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Prognostic difference according to ApoE mRNA expression. Kaplan-Meier survival curves (Fig. 3 ) revealed that patients with high ApoE expression tumor showed significantly poorer prognosis than those with low ApoE expression (p=0.0324; log-rank test). The overall survival rate at five years in the high ApoE expression group was 58.6%, while that of low ApoE expression group was 36.8%.
Relationship between ApoE expression and clinicopathologic factors. The differences between the low and high expression groups based on clinicopathologic factors are summarized in Table I . The Chi-square test was used for statistical analysis. Factors such as age and gender did not significantly differ between the two groups. However, there were significant differences when deeper tumor invasion and more positive lymph node metastasis were considered.
Patients with high ApoE expression tumor frequently showed deeper tumor invasion than those with low ApoE expression tumor. Muscular invasion and serosal invasion were significantly higher in the high ApoE expression group than in the low ApoE expression group (p<0.0001 and p=0.0059, respectively). Muscular invasion was observed in 59 of 62 (95.2%) cases in the high ApoE expression group, and in 35 of 62 (56.5%) cases in the low ApoE expression group. Serosal invasion accounted for 33 of 62 (53.2%) cases in the high ApoE expression group, and 18 of 62 (29.0%) in the low ApoE expression group.
The incidence of lymph node metastasis was also significantly higher in the high ApoE expression group than in the low ApoE expression group (p=0.0156). The cases with positive lymph node metastasis were 45 of 56 (72.6%) in the high ApoE expression group, and 32 of 62 (51.6%) in the low ApoE expression group. The incidence of lymphatic permeation was also more frequently observed in the high ApoE expression group than in the low ApoE expression group (p=0.0504). No significant differences were observed in histological type, distant metastasis, venous permeation and peritoneal dissemination.
Multivariate analysis. High ApoE mRNA expression was not an independent indicator for overall survival, based on the results of Cox multivariate analysis (data not shown, RR:1.05, 95%CI:0.78-1.43, p=0.7565). Since ApoE mRNA expression was closely correlated with positive lymph node metastasis, we performed multivariate analysis for lymph node metastasis (Table II) . However, high ApoE mRNA expression was not an independent indicator for lymph node metastasis (RR:1.50, 95%CI:0.54-4.13, p=0.4290). The most influential factors for lymph node metastasis were positive lymphatic permeation (p<0.0001) and positive serosal invasion (p=0.0088).
Since elevated ApoE expression was involved in muscular invasion with the most significance (Table I ), a positive relationship between ApoE expression and lymph node metastasis would be likely observed through the relationship between ApoE expression and deeper tumor invasion into the gastric wall. We hypothesized that ApoE may play a critical role in tumor invasion into the muscle layer. Since, in this study, all tumors >5 cm in diameter showed deeper invasion than the muscle layer, tumors <5 cm (n=61) were entered into the multivariate analysis for muscular invasion (Table III) . The factors affecting muscular invasion were determined by comparing high ApoE mRNA expression with undifferentiated type, tumor size >3 cm in diameter and a positive ulcerative area in tumor. As a result, high ApoE mRNA expression was revealed as an independent factor for muscular invasion (RR: 65.24, 95%CI: 6.41-2478.96, p=0.0035).
Discussion
Real-time quantitative RT-PCR assay for 124 clinical bulk samples revealed that ApoE mRNA expression was frequently higher in gastric cancer tissue than in the corresponding normal tissue (Fig. 1) . However, it has been reported that ApoE is synthesized in a wide variety of peripheral cells (21, 22) . Furthermore, Niemi et al suggested that ApoE may be secreted from stromal cells surrounding the tumor (23) . In this study, we prepared four paired specimens -gastric cancer and adjacent normal epithelium were dissected using an LMD system to avoid contamination with stromal cells and necrotic tissues -and compared ApoE mRNA expression in gastric cancer with that in normal epithelium ( Fig. 2A) . It was subsequently confirmed that overexpression of ApoE mRNA in bulk samples was derived from gastric cancer. An additional immunohistochemical study also showed that ApoE protein was predominantly expressed in gastric cancer (Fig. 2B) . Taking into consideration Kaplan-Meier survival curves indicating shorter survival among patients with high ApoE expression tumor (Fig. 3) , ApoE in gastric cancer could play a critical role in tumor progression. Consistent with our date, Chen et al disclosed that ApoE is positively correlated with the development of ovarian cancer (14) . According to their study, ApoE produced from ovarian cancer cells may bind to the LDL receptor via autocrine or paracrine mechanism, and serve as a trigger to activate certain downstream signal transductions, resulting in tumor cell growth. Thus, we consider that ApoE may contribute to gastric cancer development in a similar manner.
The most important aspect of this study is the evidence that gastric cancers with high ApoE expression tended to show deeper tumor invasion or more positive lymph node metastasis ONCOLOGY REPORTS 20: 1313 -1319 Table I. The relationship between ApoE expression and histopathologic factors. 
b Differentiated type, including well/moderately differentiated adenocarcinoma; c Undifferentiated type, including signet ring cell carcinoma, mucinous adenocarcinoma and poorly differentiated adenocarcinoma. SD, standard deviation; N.S., not significant. (Table I) . Furthermore, ApoE was also closely correlated with positive pathologically lymph node permeation (Table I) . These results are in agreement with our hypothesis that ApoE may show biological activity for promotion of lymph node metastasis in gastric cancer. However, high ApoE mRNA expression was not a very reliable indicator for lymph node metastasis by multivariate analysis (Table II) . High ApoE mRNA expression showed a close correlation with muscular invasion rather than lymph node metastasis (Table III) . For gastric cancers confined to mucosal or submucosal regions, endoscopic resection is a valid choice of curative treatment. Histological cell type, tumor size and the presence of ulcerative change determine whether the tumors are eligible for endoscopic resection (2) . Endoscopic ultrasonography (EUS) has been clinically applied as a valuable diagnostic modality for more accurate predictions of the depth of tumor invasion. However, Akashi et al reported that the presence of ulcerative change in a tumor decreases correct EUS diagnosis of tumor depth (24, 25) . Since high ApoE mRNA expression was one of the factors predicting the likelihood of muscular invasion, incorporating genetic diagnosis of ApoE expression with EUS technology would help in selecting eligible cases for endoscopic resection.
The current study, for the first time, showed a positive correlation between biological aggressiveness of gastric cancers and high ApoE expression. However, we need to take note of the presence of three common isoforms, ApoE2, E3 and E4, resulting from amino acid substitutions (26, 27) . Interestingly, it is known that these distinct substitutions affect the binding affinity between ApoE and the LDL receptor. Since ApoE achieves its roles by binding to the LDL receptor, the difference in binding affinity could cause a variety of biological behaviors for tumor growth (28) (29) (30) . According to Zunarelli et al, the possession of ApoE4, which shows the greatest binding affinity to the LDL receptor, is associated with better prognosis in patients with brain tumor (31) . The different ApoE phenotypes may have some influence on the result of this study, and future research stratified by phenotypic variation is required.
In conclusion, ApoE was highly expressed in gastric cancer. Patients with high ApoE expression tumor showed frequent deeper tumor invasion or more positive lymph node metastasis, resulting in shorter survival. In particular, ApoE was closely correlated with tumor invasion into the muscle layer. Although further research is required, ApoE may be a possible detection modality for the prediction of muscular invasion in gastric cancer. Table II . Multivariate analysis for lymph node metastasis. ---------------------------------------------------------------------------------------------------- a Undifferentiated type, including signet ring cell carcinoma, mucinous adenocarcinoma and poorly differentiated adenocarcinoma. N.S., not significant; 95%CI; 95% confidence interval. Table III . Multivariate analysis for muscular invasion. 
indicators for lymph node metastasis Relative risk (95%CI) P-value -----------------------------------------------------------------------------------------------------

-----------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------Candidate indicators for muscular invasion Relative risk (95%CI) P-value -----------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------
This analysis was done regarding gastric cancers which were <5 cm in diameter.
a Undifferentiated type, including signet ring cell carcinoma, mucinous adenocarcinoma and poorly differentiated adenocarcinoma. N.S., not significant. 95%CI, 95% confidence interval.
